Ganaxolone

  • Part D specialty tier in 79% of formularies (2026Q3)
  • ZTALMY

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Ganaxolone: storage and handling

Freezing
Not addressed
Room temperature
at or below 30°C (86°F)
Label statement
Store ZTALMY in its original bottle in an upright position at 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
Back into the refrigerator
Not addressed
Light
Not addressed
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (at up to 30°C (86°F)). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

Store ZTALMY in its original bottle in an upright position at 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
Use within 30 days of first opening the bottle, then discard any remainder.

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1-844-627-4687 (the number printed on the label) about this product.

Where the label prints this number
Helpline Details For additional assistance, call the toll-free helpline at 844-IMMEDICA (1-844-627-4687).
All storage statements on the label (4)
  • Store ZTALMY in its original bottle in an upright position at 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
  • Use within 30 days of first opening the bottle, then discard any remainder.
  • Store ZTALMY at 68°F to 77°F (20°C to 25°C).
  • Always store ZTALMY in its original bottle in an upright position.

FDA label version 13, effective November 28, 2025. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

100%of plans list it
96%of those: prior authorization
0%step therapy
76%quantity limit
96%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.